United States securities and exchange commission logo

                      January 4, 2023

       Fred Powell
       Chief Financial Officer
       LAVA Therapeutics N.V.
       520 Walnut St, Suite 1150
       Philadelphia, PA 19106

                                                        Re: LAVA Therapeutics
                                                            Form 20-F for the
Fiscal Year Ended December 31, 2021
                                                            Filed March 24,
                                                            File No. 001-40241

       Dear Fred Powell:

              We have completed our review of your filings. We remind you that
the company and its
       management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding
       any review, comments, action or absence of action by the staff.


                      Division of Corporation Finance

                      Office of Life Sciences